stella
beta
A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia — Stella
Recruiting
Back to Waldenström Macroglobulinemia trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Dana Farber Cancer Institute, Boston, Massachusetts
View full record on ClinicalTrials.gov